LT2555776T - Adenozino a1 agonistų ir neselektyvių beta adrenerginių receptorių blokatorių derinio kompozicijos, skirtos akispūdžio mažinimui - Google Patents

Adenozino a1 agonistų ir neselektyvių beta adrenerginių receptorių blokatorių derinio kompozicijos, skirtos akispūdžio mažinimui

Info

Publication number
LT2555776T
LT2555776T LTEP11757065.5T LT11757065T LT2555776T LT 2555776 T LT2555776 T LT 2555776T LT 11757065 T LT11757065 T LT 11757065T LT 2555776 T LT2555776 T LT 2555776T
Authority
LT
Lithuania
Prior art keywords
adenosine
agonists
intraocular pressure
adrenergic receptor
receptor blockers
Prior art date
Application number
LTEP11757065.5T
Other languages
English (en)
Inventor
Norman N. Kim
William K. Mcvicar
Thomas G. Mccauley
Original Assignee
Inotek Pharmaceuticals Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inotek Pharmaceuticals Corporation filed Critical Inotek Pharmaceuticals Corporation
Publication of LT2555776T publication Critical patent/LT2555776T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LTEP11757065.5T 2010-03-19 2011-03-18 Adenozino a1 agonistų ir neselektyvių beta adrenerginių receptorių blokatorių derinio kompozicijos, skirtos akispūdžio mažinimui LT2555776T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31573110P 2010-03-19 2010-03-19
PCT/US2011/029012 WO2011116292A1 (en) 2010-03-19 2011-03-18 Combination compositions of adenosine a1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure

Publications (1)

Publication Number Publication Date
LT2555776T true LT2555776T (lt) 2017-04-25

Family

ID=44649621

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11757065.5T LT2555776T (lt) 2010-03-19 2011-03-18 Adenozino a1 agonistų ir neselektyvių beta adrenerginių receptorių blokatorių derinio kompozicijos, skirtos akispūdžio mažinimui

Country Status (17)

Country Link
US (1) US8455457B2 (lt)
EP (1) EP2555776B1 (lt)
JP (1) JP2013522323A (lt)
CN (1) CN102958526A (lt)
CY (1) CY1118483T1 (lt)
DK (1) DK2555776T3 (lt)
ES (1) ES2613255T3 (lt)
HR (1) HRP20170009T1 (lt)
HU (1) HUE031530T2 (lt)
LT (1) LT2555776T (lt)
ME (1) ME02594B (lt)
PL (1) PL2555776T3 (lt)
PT (1) PT2555776T (lt)
RS (1) RS55616B1 (lt)
SI (1) SI2555776T1 (lt)
SM (2) SMT201700020T1 (lt)
WO (1) WO2011116292A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596428A (en) * 2009-05-01 2014-03-28 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans
LT2523669T (lt) * 2010-01-11 2017-04-25 Inotek Pharmaceuticals Corporation Akispūdžio mažinimo būdas, derinys ir rinkinys
PH12012501906A1 (en) 2010-03-26 2013-01-14 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans using n6 -cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof
PT2807178T (pt) 2012-01-26 2017-08-08 Inotek Pharmaceuticals Corp Polimorfos anidros de nitrato de (2r,3s,4r,5r)-5-(6-(ciclopentilamino)-9h-purin-9-il)-3,4-dihidroxitetrahidrofuran-2-il)}metilo e seus processos de preparação
NZ630759A (en) 2013-03-15 2017-07-28 Inotek Pharmaceuticals Corp Ophthalmic formulations comprising an a1 agonist
KR20150138182A (ko) * 2013-03-15 2015-12-09 이노텍 파마슈티컬스 코포레이션 안구 신경보호를 제공하는 방법
WO2016090005A1 (en) * 2014-12-03 2016-06-09 Inotek Pharmaceuticals Corporation Methods of preventing, reducing or treating macular degeneration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE418991T1 (de) * 2002-04-18 2009-01-15 Cv Therapeutics Inc Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker
GB2436255B (en) * 2002-12-23 2007-11-28 Global Cardiac Solutions Pty L Organ preconditioning, arrest, protection, preservation and recovery
CN103087133B (zh) * 2004-05-26 2016-09-14 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
CN101010085B (zh) * 2004-05-26 2012-12-26 伊诺泰克制药公司 嘌呤衍生物作为腺苷a1受体激动剂及其用法
EA015683B1 (ru) * 2005-11-30 2011-10-31 Инотек Фармасьютикалз Корпорейшн Производные пурина и способы их применения
WO2009076580A2 (en) * 2007-12-12 2009-06-18 Thomas Jefferson University Compositions and methods for the treatment and prevention of cardiovascular diseases
NZ596428A (en) * 2009-05-01 2014-03-28 Inotek Pharmaceuticals Corp Method of reducing intraocular pressure in humans

Also Published As

Publication number Publication date
EP2555776A4 (en) 2013-08-28
RS55616B1 (sr) 2017-06-30
US20110251151A1 (en) 2011-10-13
WO2011116292A1 (en) 2011-09-22
EP2555776B1 (en) 2016-12-07
ME02594B (me) 2017-06-20
CY1118483T1 (el) 2017-07-12
DK2555776T3 (en) 2017-02-06
HUE031530T2 (en) 2017-07-28
PL2555776T3 (pl) 2017-08-31
CN102958526A (zh) 2013-03-06
EP2555776A1 (en) 2013-02-13
SMT201700020B (it) 2017-03-08
ES2613255T3 (es) 2017-05-23
SMT201700020T1 (it) 2017-03-08
PT2555776T (pt) 2017-02-01
SI2555776T1 (sl) 2017-05-31
JP2013522323A (ja) 2013-06-13
HRP20170009T1 (hr) 2017-03-10
US8455457B2 (en) 2013-06-04

Similar Documents

Publication Publication Date Title
HUS2000017I1 (hu) S1P receptor agonista adagolási rendje
SI2555776T1 (sl) Kombinirani sestavki adenozin A1 agonistov in ne-selektivni blokatorji beta-adrenergičnega receptorja za zmanjšanje intraokularnega tlaka
ZA201005817B (en) Parenteral formulations of dopamine agonists
ZA201402975B (en) Derivatives of 6-substituted triazolopyridazines as rev-erb agonists
ZA201204138B (en) Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors
PL2477987T3 (pl) Modulatory receptorów toll-podobnych
IL218649A0 (en) Oxytocin receptor agonists
ZA201702958B (en) Novel npr-b agonists
IL220187A0 (en) Inhibitors of sphingosine kinase
SMT201700019B (it) Combinazione di composizioni di antagonisti di adenosina a1 e bloccanti di recettori non selettivi beta-adrenergici per ridurre la pressione intraoculare
IL216279A0 (en) Novel glucocorticoid receptor agonists
ZA201200641B (en) Sphingosine-1-phosphate receptor agonists
ZA201302340B (en) Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
ZA201309359B (en) Compositions for sequential administration of opioid receptor agonists
IL237150B (en) Preparations containing combinations of receptor antagonists and agonists
PL387217A1 (pl) Boranowe pochodne adenozyny
IL216114A0 (en) A3 adenosine receptor agonists for the reduction of intraocular pressure
EP2438868A4 (en) WIRBELFÜLLSTOFF
TWM385432U (en) Retaining structure of quick retainer
TWM369751U (en) Device for inspecting vagina of mammals
TWM369684U (en) Improvement of pin structure
TWM373700U (en) Improved structure of cup
PL387010A1 (pl) Urządzenie do badania powłok
TWM370358U (en) Improved design of thermal cup
ES1068610Y (es) Estructura compuesta para copa de sujetador